1. Home
  2. DORM vs TLX Comparison

DORM vs TLX Comparison

Compare DORM & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

HOLD

Current Price

$132.98

Market Cap

4.0B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.90

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DORM
TLX
Founded
1978
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
DORM
TLX
Price
$132.98
$11.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$160.25
$21.13
AVG Volume (30 Days)
324.1K
88.5K
Earning Date
05-04-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
8.14
N/A
EPS
4.35
N/A
Revenue
$2,130,319,000.00
N/A
Revenue This Year
$9.70
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
$30.53
$150.33
Revenue Growth
6.03
N/A
52 Week Low
$98.45
$6.28
52 Week High
$166.88
$12.60

Technical Indicators

Market Signals
Indicator
DORM
TLX
Relative Strength Index (RSI) 47.04 61.64
Support Level $131.69 $10.01
Resistance Level $142.43 $12.23
Average True Range (ATR) 5.93 0.19
MACD -0.72 0.14
Stochastic Oscillator 29.90 82.28

Price Performance

Historical Comparison
DORM
TLX

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: